A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.
about
Saliva of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) inhibits classical and alternative complement pathwaysHuman Coinfection with Borrelia burgdorferi and Babesia microti in the United StatesA Nod to disease vectors: mitigation of pathogen sensing by arthropod salivaIs arthropod saliva the achilles' heel of vector-borne diseases?Hide and Seek: How Lyme Disease Spirochetes Overcome Complement AttackIxodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut.Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathwayAmblyomma americanum tick saliva serine protease inhibitor 6 is a cross-class inhibitor of serine proteases and papain-like cysteine proteases that delays plasma clotting and inhibits platelet aggregationPopulation bottlenecks during the infectious cycle of the Lyme disease spirochete Borrelia burgdorferiA tick gut protein with fibronectin III domains aids Borrelia burgdorferi congregation to the gut during transmissionImmunity-related genes in Ixodes scapularis--perspectives from genome informationVaccination against Lyme disease: past, present, and futureInnate immunity networks during infection with Borrelia burgdorferi.Early immunologic events at the tick-host interfaceThe relapsing fever spirochete Borrelia miyamotoi is cultivable in a modified Kelly-Pettenkofer medium, and is resistant to human complement.Tsetse GmmSRPN10 has anti-complement activity and is important for successful establishment of trypanosome infections in the fly midgutAnopheles midgut epithelium evades human complement activity by capturing factor H from the blood meal.Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or OvipositionTransmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne DiseasesIxodes scapularis saliva mitigates inflammatory cytokine secretion during Anaplasma phagocytophilum stimulation of immune cells.Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.Sialomes and Mialomes: A Systems-Biology View of Tick Tissues and Tick-Host Interactions.Improved culture conditions for the growth and detection of Borrelia from human serum.Partial characterization of a novel anti-inflammatory protein from salivary gland extract of Hyalomma anatolicum anatolicum 77Acari: Ixodidae) ticks.Tick vaccines and the control of tick-borne pathogens.Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularisInteraction of the tick immune system with transmitted pathogensImmunomodulatory effects of tick saliva on dermal cells exposed to Borrelia burgdorferi, the agent of Lyme disease.Tick salivary compounds: their role in modulation of host defences and pathogen transmissionVariable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoiFactor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment.De novo Ixodes ricinus salivary gland transcriptome analysis using two next-generation sequencing methodologies.Tick infestation patterns in free ranging African buffalo (Syncercus caffer): Effects of host innate immunity and niche segregation among tick species.Hard tick factors implicated in pathogen transmission.ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.Tick Thioester-Containing Proteins and Phagocytosis Do Not Affect Transmission of Borrelia afzelii from the Competent Vector Ixodes ricinus.Tick-Pathogen Interactions and Vector Competence: Identification of Molecular Drivers for Tick-Borne Diseases.Lyme disease: aetiopathogenesis, factors for disease development and control.Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and Anaplasma phagocytophilum Infection
P2860
Q26700083-42A5853B-A3E7-4185-9CA8-8E157209700AQ26772263-7FAD5C30-41D1-45E4-9F51-62F84DD693FFQ26830623-3B39628B-6D2D-4A34-A23B-05F3DA3CDD4FQ26865242-7F8CD74E-383A-4BD9-97FE-ADEFDC3951F0Q28071981-D39139B4-632C-439D-99BB-B19ABD4A2280Q30381683-C03CD2EF-4264-4504-8A6D-4660BE681CCAQ33650125-54845020-4D5B-4F62-AEEC-451BAFB8F5DEQ33758083-19C4CC99-B20E-4356-A965-46C53BE453DCQ33825799-AD714077-6EC8-4347-BE63-979A6764C048Q34016050-D9024908-ED2A-4193-A48D-9AF1044676B4Q34077586-DF4640BA-C961-4810-A1A5-F301B0029950Q34327726-7A89C55C-FA24-457A-A043-5166460A9880Q34426426-7E151ACC-EBEB-4C11-9D28-3F19DDEE0D56Q34450717-6202CADE-68DC-4E52-835A-8ED3F0589A47Q34667316-EDA80565-F432-40A7-814A-30A12E838E91Q34875379-5DAD5557-1466-4022-AB81-4F02E69FB760Q35094883-8BBF736E-231E-436A-969D-579FD2E3E5F5Q35547214-9A8B0894-A100-448D-80D2-DDC70818A8DAQ35598662-CE28C62D-EFF7-41C4-A80F-F55B8AEEB202Q36416025-42ECB596-626F-4E12-A8CA-37F1D192B6E4Q36588072-B14D5C3E-5C9A-4D80-94D6-17BC014A8480Q36619944-FBED784C-7DAB-461B-B013-3DC00AC80FE6Q36663368-772D6952-8F76-409D-B824-D36F7C0C0B01Q36779667-EF1CC404-2558-4E8D-8504-F9D7EBC9BA5DQ36993703-B6D1D182-732D-4BF4-A70A-4DA5EA6B071AQ36997428-BC7ABD8D-043B-4533-9631-90EAA5E26348Q37017666-D4666863-32F3-4A1A-85DB-9B7E73A1988FQ37080249-949A6FC9-3B37-4203-8144-75F61F541645Q37105032-961DB303-38BB-4439-B926-8BB924652099Q37225179-DEA02EB2-6A6D-41B5-A5CC-33BDC91E5D24Q37303864-A9E9E982-4EF3-4369-BB82-9E9986D0532FQ37322741-762A787A-3612-4973-ADC0-0FF3DEA9324EQ37327457-900727FC-B892-4F52-B184-D6B47B7CDE00Q37390725-49C20909-BB32-4FFA-9E29-784CD57A9DF7Q37533910-9580DB94-48E8-4B20-B9FF-55AD6D057931Q37600954-244E8DC9-D23D-46BC-BFD9-24C64905B3DCQ37703102-1533E0BF-E041-460F-A056-489CE8CE1475Q37740572-A0D49562-4B71-45A7-9F03-5A36F219DE09Q38056621-87AF0C3B-F6DB-4E95-B61A-7E9C044BB892Q38604707-69E2EBFC-9988-42B9-950F-964EC873F6BB
P2860
A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@ast
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@en
type
label
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@ast
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@en
prefLabel
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@ast
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@en
P2093
P2860
P50
P1433
P1476
A tick mannose-binding lectin ...... ion of the lyme disease agent.
@en
P2093
Alje P van Dam
Anneke Oei
Cornelis Van't Veer
Diana Wouters
Jeroen Coumou
Jianfeng Dai
Joppe W Hovius
Joris J T H Roelofs
Kathleen Deponte
Mieke Brouwer
P2860
P304
P356
10.1016/J.CHOM.2011.06.010
P577
2011-08-01T00:00:00Z